1. Zhang, P.J., Wei, Y.K., Wang, L., Debeb, B.G., Yuan, Y., Zhang, J.S., Yuan, J.S., Wang, M., Chen, D.H., Sun, Y.T., Woodward, W.A., Liu, Y.Q., Dean, D.C., Liang, H., Hu, Y., Ang, K.K., Hung, M-C., Chen, J.J., Ma, L. (2014) ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nature Cell Biology, 16, 864-875.
2. Zhang, P.J., Wang L., Rodriguez-Aguayo C.,Yuan Y., Debeb, B.G., Chen, D.H., Sun Y.T., You, M.J., Liu, Y.Q., Dean, D.C., Woodward, W.A., Liang, H., Yang, X.B., Lopez-Berestein, G., Sood, A.K., Hu, Y., Ang, K.K., Chen, J.J., Ma, L. (2014) miR-205 acts as a tumor radiosensitizer by targeting ZEB1 and Ubc13. Nature Communications. 5; 5:5671. doi: 10.1038/ncomms6671.
3. Wang, L.,* Zhang, P.J.,* Molkentine, D.P., Piao, H.L., Chen, C.Y., Molkentine, J.M., Zhang, J.S., Valdecanas, D.R.,Thames, H., Skinner, H., Buchholz, T.A., Chen, J.J., Ma, L., Mason, K., Ang, K.K., Jr, R.M. (2016) Discovery of Trip12 as a novel mediator of HPV/p16 related radiation enhancement effects. Oncogene, 36, 820-828.（*共同第一作者）
4. Zhang, P.J., Sun, Y.T., Ma, L. (2015) ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle, 14:4, 481-487.
5. Chen, D.H., Sun, Y.T., Wei, Y.K., Zhang, P.J., Rezaeian, A.H., Teruya-Feldstein, J., Gupta, S., Liang, H., Lin, H-K., Hung, M-C., Ma, L. (2012) LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nature Medicine 18, 1511-1517. |
